Largest insider trades of the week Continue reading...
Incomplete testing fails to meet current medical guideline standards, placing more than 80 percent1 of patients at increased risk of receiving a less effective treatment.
Guardant Health posted a strong first-quarter beat, sending Guardant Health stock briefly into breakout territory Friday even after the diagnostics company pulled its 2020 outlook.
There are a few fantastic growth stocks that you can buy right now that have a good shot at making you a lot of money relatively quickly. David Gardner, co-founder of The Motley Fool, thinks that investors should "make your portfolio reflect your best vision for our future." One really positive vision for the future is a world where most cases of cancer can be detected early enough to be successfully treated.
Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify
Zacks.com featured highlights include: Vista Outdoor, Guardant Health, Computer Programs and Systems, MicroStrategy and Sibanye Gold
REDWOOD CITY, Calif., May 07, 2020 -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its.
It's been a mediocre week for Guardant Health, Inc. (NASDAQ:GH) shareholders, with the stock dropping 13% to US$75.79...
Guardant Health (GH) closed the most recent trading day at $65.84, moving +0.72% from the previous trading session.
Forget earnings growth, bet on these top-ranked stocks to cash in on earnings beat.
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
Ladies and gentlemen, thank you for standing by, and welcome to the Guardant Health Q1 2020 Earnings Call. Earlier today, Guardant Health released financial results for the quarter ended March 31, 2020.
REDWOOD CITY, Calif., May 15, 2020 -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data highlighting.
Guardant Health (GH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
As of late, it has definitely been a great time to be an investor Guardant Health
REDWOOD CITY, Calif., April 30, 2020 -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the first quarter 2020 after market close on.
Consider investing it in one of these hot growth stocks and holding your position for at least five years. Alteryx (NYSE: AYX) solves this problem. Users love Alteryx's software so much that it won the 2019 Gartner Peer Insights Customers' Choice award for data science and machine learning platforms.
REDWOOD CITY, Calif., May 06, 2020 -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming BofA Securities Virtual Healthcare.
Guardant Health, Inc. (GH) presents new data at Digestive Disease Week (DDW) 2020 that highlights the performance of its LUNAR-2 assay and reinforces its potential to improve colorectal cancer (CRC) screening rates by offering a simpler blood test that overcomes barriers associated with current testing methods. “Despite the recent challenges of the COVID-19 pandemic, the ability to hold scientific discussions on research of cancer and other diseases, even in a virtual capacity like this year’s DDW, is essential to ensure our collective fight against cancer continues to advance,” said Helmy Eltoukhy, PhD, co-founder and CEO. Abstract #Sa1651 and Poster of Distinction: Plasma based cell-free circulating tumor DNA (ctDNA) assessment for non-invasive detection of colorectal cancer (CRC).
REDWOOD CITY, Calif., April 09, 2020 -- Many women with metastatic hormone receptor-positive (HR+) breast cancer have experienced improved clinical outcomes with the recent.